HER2, also known as Neu, ErbB-2, CD340 or p185, is an oncoprotein amplified or over-expressed in ~30% of breast cancers (BC) and other tumours, strongly associated with increased disease recurrence and worse prognosis (91). This evidence concerns the gene ERBB2 and breast carcinoma.